Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > Ovarion results keep getting better
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(258)
•••
Comment by qwerty22on Nov 11, 2020 3:27pm
191 Views
Post# 31878977

RE:Ovarion results keep getting better

RE:Ovarion results keep getting better

Aug Ovarian
Nov dlbcl
You're mixing up indications. CRs in Ovarian would be amazing but they don't have them


cribbons wrote: Aug 12 press release showed 5 of 19 (27%) partial regression  PR.
Nov 9  press release showed 6 of 7  (87%)  of PD-1 positive patiants   3  PR and 3  CRs     Does this mean the CRs just showed up between Aug and Sept?    Wow maybe it is time to back up the truck and go all in. Am I wrong or is this whaat we haave been waiting for?

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities